BIO 2019 - Browse Agenda

All Sessions

9:00 AM–10:15 AM

Jun 6, 2019

Re-Imagining Clinical Trials: Ideas and Early Feedback on New Trial Designs

105AB, Level 100

Speakers

Amy McKeeVice President, Regulatory Consulting Services atPAREXEL International

Dr. Donald BerryProfessor atUniversity of Texas

Vimal MehtaBioXcel Therapeutics

Dr. Mark StewartVice President, Science Policy atFriends of Cancer Research

9:00 AM–10:15 AM

Jun 6, 2019

Orphan and Rare Diseases

Swinging for the Fences: The Dichotomy in Rare Disease Investment and Development

106AB, Level 100

Speakers

Christopher N. MaraiManaging Director and Senior Analyst, Biotechnology atNomura Instinet

Brian BronkHead of Business Development, Rare Diseases & Rare Blood Disorders, Global BD&L atSanofi

Jim HealyGeneral Partner atSofinnova Ventures

Dr. Jeffrey MarrazzoCEO atSpark Therapeutics, Inc.

Wendy WhiteBoard Chair, Global Genes and Chief Patient Officer atVitrisa Therapeutics

9:00 AM–10:15 AM

Jun 6, 2019

digitalhealth_icon

The Hype, the Promise and the Reality of Artificial Intelligence in Personalized Medicine

104AB, Level 100

Speakers

Tom ChittendenVice President, Statistical Sciences Founding Director, atWuXi NextCODE Genomics

Brandon AllgoodCTO atNumerate

Andrea de SouzaSenior Director atEli Lilly and Company

Annastasiah Mudiwa MhakaSenior Advisor atAlliance for Artificial Intelligence in Healthcare

9:15 AM–10:45 AM

Jun 6, 2019

bio2018-mybio-sessionicon-networking

Success Story: How a French Biotech Company Leveraged Massachusetts to Enter the U.S. Market?

French Pavilion - Booth 2109

Speakers

Travis McCreadyPresident and CEO atMassachusetts Life Science Center

Patrick TricoliCEO atNanobiotix Corp.

10:00 AM–4:30 PM

Jun 6, 2019

bio2018-mybio-sessionicon-networking

Barrington James Limited - Booth: 3736 In-Booth Activity

3736

10:00 AM–4:30 PM

Jun 6, 2019

bio2018-mybio-sessionicon-networking

GE Healthcare Life Science - Booth: 3519,4101 In-Booth Activity

3519, 4101

10:00 AM–4:30 PM

Jun 6, 2019

bio2018-mybio-sessionicon-networking

Headshot Lounge - Thursday

Booth 4335, Hall E

10:00 AM–4:00 PM

Jun 6, 2019

bio2018-mybio-sessionicon-networking

Illingworth Research Group Ltd - Booth: 3141 In-Booth Activity

3141

10:00 AM–4:00 PM

Jun 6, 2019

bio2018-mybio-sessionicon-networking

ManagedLab Services - Booth: 3658 In-Booth Activity

3658

10:30 AM–12:00 PM

Jun 6, 2019

emergingopp_icon

Emerging Opportunities in Global Markets

Emerging Biotherapeutics in India: Opportunities and Evolving Regulations in Cell and Gene Therapies

115B, Level 100

Speakers

Dr. Guljit ChaudhriChief, Managing Director atInnonation, ABLE, Bioinnovat

Dr. Manolo BeelkeSVP - Scientific and Medical Affairs atNavitas Life Sciences

Mr. Manohar B NManaging Director & CEO atStempeutics Research Pvt. Ltd.

Dr. Cyrus KarkariaPresident atLupin Limited

Bruce LevineBarbara and Edward Netter Professor in Cancer Gene Therapy atUniversity of Pennsylvania

Dr. Snehal NaikAssociate Director, Global Regulatory Affairs atJanssen

Mr. Ashu TandonChief Commercial Officer atSyngene International Ltd.

10:30 AM–11:00 AM

Jun 6, 2019

bio2018-mybio-sessionicon-networking

European Commission - Booth: 2701 In-Booth Activity

2701

10:30 AM–12:00 PM

Jun 6, 2019

Immuno-Oncology: Taking Immunotherapies to the Next Level

105AB, Level 100

Speakers

Jeffrey BockmanEVP, Oncology Practice Head atCello Health BioConsulting (Previously Defined Health)

Jennifer BuellChief Operating Officer atAgenus, Inc.

Asthika GoonewardeneSenior Biotechnology Analyst atBloomberg Intelligence

Bibhash MukhopadhyayPrincipal atNew Enterprise Associates (NEA)

Drew PardollAbeloff Professor of Oncology, Medicine, Pathology and Molecular Biology and Genetics atJohns Hopkins Sidney Kimmel Comprehensive Cancer Center,

Helen SabzevariPresident atPrecigen

Emmett SchmidtAssociate Vice President atMerck & Co., Inc.

10:30 AM–11:45 AM

Jun 6, 2019

emergingopp_icon

Emerging Opportunities in Global Markets

Innovative Contracting in Cell and Gene Therapies in Europe

115A, Level 100

Speakers

Dr. Alexander NatzSecretary General atEuropean Confederation of Pharmaceutical Entrepreneurs (Belgium)

Sonalee AgarwalVP Value Evidence & Strategy atAlnylam Pharmaceuticals

Fabian BerkemeierDirector of Value & Access Strategy atIGES Institute

Jie ZhangHead of Global Value and Access atNovartis Pharmaceuticals Corporation

10:30 AM–11:45 AM

Jun 6, 2019

Orphan and Rare Diseases

Rare Finds: Innovative Clinical Trial Design for Rare and Orphan Diseases

106AB, Level 100

Speakers

Aileen HealyExecutive Director, Global Head, ES&I for Rare Diseases, Worldwide R&D atPfizer

Jonathan FoxPresident and CMO atEidos

Angi RobinsonVP, Clinical Development Services, Rare Disease and Pediatrics atPremier Research

Julie Anne SmithPresident and Chief Executive Officer atE-Scape Bio

10:30 AM–11:45 AM

Jun 6, 2019

digitalhealth_icon

Realizing the Promise of Innovative Digital Health Solutions: A Path Toward Treating the Whole Patient

104AB, Level 100

Speakers

Rob WrightChief Editor atLife Science Leader Magazine

Chandra RamanathanVice President & Head, East Coast Innovation Center atBayer

Herb RyanCo-founder and CEO atBitome Inc.

Kerry WillisChief Scientific Officer atNational Kidney Foundation

10:30 AM–1:00 PM

Jun 6, 2019

bio2018-mybio-sessionicon-companypres

Start-Up Stadium - Thursday, June 6: 10:30 AM - 1:00 PM

Hall E, Booth 3971, Level 200

10:30 AM–11:45 AM

Jun 6, 2019

Business Development and Finance

The Evolving Landscape of Venture Capital

107AB, Level 100

Speakers

Dr. Mankit LawSenior Associate atPappas Capital

Jennifer HuAdvant VC Investment and BD&L atAdvisor

Dr. Emmanuel LacroixPartner atUCB Ventures

Dr. Jim TrenkleVice President atPivotal Bioventure Partners

10:30 AM–11:45 AM

Jun 6, 2019

personalmedicine

Personalized Medicine and Diagnostics

The Secret Recipe to Maximizing Deals in Precision Medicine

116, Level 100

Speakers

Kristin PothierManaging Director and Global Head of Life Sciences Strategy, Transaction Advisory Services atErnst & Young LLP

John BoyceManaging Director and Co-Founder atTigerGene LLC

Mr. Ricardo JohnsonHead of Healthworx (Innovation and Strategic Investments) atCareFirst BlueCross BlueShield

Josh LauerGlobal Head of Personalized Healthcare Market Development atRoche

Anushka SunderPrincipal atBlackstone

10:45 AM–12:00 PM

Jun 6, 2019

bio2018-mybio-sessionicon-companypres

Company Presentations - Thursday, June 6: 10:45 AM - 12:00 PM

Theaters 1-4

11:00 AM–11:45 AM

Jun 6, 2019

bio2018-mybio-sessionicon-networking

BioProcess Theater, Day 3

BioProcess Theater: Booth #3211

11:00 AM–2:00 PM

Jun 6, 2019

bio2018-mybio-sessionicon-networking

Celeritas Solutions, LLC - Booth: 2641 In-Booth Activity

2641

11:00 AM–11:15 AM

Jun 6, 2019

bio2018-mybio-sessionicon-networking

Department of Defense - Booth: 621 In-Booth Activity

621

11:45 AM–12:00 PM

Jun 6, 2019

bio2018-mybio-sessionicon-networking

Department of Defense - Booth: 621 In-Booth Activity

621

12:00 PM–1:30 PM

Jun 6, 2019

bio2018super_sessions

Nature Biotechnology and Scientific American WORLDVIEW: Biotech Innovation in a Faster Future

113ABC, Level 100

Speakers

Andrew MarshallChief Editor atNature Biotechnology

Maina BhamanPartner, Capital Funds atSofinnova

Katherine HighPresident and Head of Research and Development atSpark Therapeutics

Dr. Zhi HongCo-founder, President, and Chief Executive Officer atBrii Biosciences

Bernard MunosSenior Fellow, FasterCures; Founder, InnoThink Center for Research in Biomedical Innovation atFaster Cures, InnoThink

Vicki Seyfert-MargolisFounder and CEO atMy Own Med, Inc.

Nick SpringPartner, Life Sciences USA atALTEN Calsoft Labs

1:00 PM–3:30 PM

Jun 6, 2019

bio2018-mybio-sessionicon-companypres

Company Presentations - Thursday, June 6: 1:00 PM - 3:30 PM

Theaters 1-4